CELLECTIS - ADR
CLLS · NASDAQ
Updated at 2026-10-14 09:20:46
- Today's High
- $1.17
- Today’s Low
- $1.09
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.25
- Previous Close
- $1.18
- Volume
- 122.57K
- Market Cap
- $81.58M
- P/E Ratio
- --
- EPS
- $-0.82
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 8, RUE DE LA CROIX JARRY, PARIS, FRANCE, 75013
- Country
- FR
- Listing Date
- 2007-02-06
- Fiscal Year End
- December
- Shares Outstanding
- 72.09M
- CIK
- 0001627281
- Website
- www.cellectis.com
Cellectis SA, a clinical-stage biotechnology company, develops immuno-oncology products based on gene-edited T cells that express chimeric antigen receptors to attack and eradicate cancer cells. The company is headquartered in Paris, France.
Financial Metrics
Revenue
2026-06-30
$5.22M
2026-03-31
$5.79M
2025-12-31
$10.39M
2025-09-30
$35.17M
Operating Expenses
2026-06-30
$26.26M
2026-03-31
$28.34M
2025-12-31
$24.74M
2025-09-30
$24.77M
Net Income
2026-06-30
-$21.78M
2026-03-31
-$17.82M
2025-12-31
-$26.31M
2025-09-30
$589K
Net Profit Margin
2026-06-30
-417.26%
2026-03-31
-307.51%
2025-12-31
-253.15%
2025-09-30
1.67%
Earnings Per Share
2026-06-30
$-0.22
2026-03-31
$-0.18
2025-12-31
$-0.24
2025-09-30
$0.02
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$21.03M
2026-03-31
-$22.54M
2025-12-31
-$19.6M
2025-09-30
$7.7M
Effective Tax Rate
2026-06-30
7.03%
2026-03-31
8.85%
2025-12-31
1.58%
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $5.22M | $5.79M | $10.39M | $35.17M |
| Operating Expenses | $26.26M | $28.34M | $24.74M | $24.77M |
| Net Income | -$21.78M | -$17.82M | -$26.31M | $589K |
| Net Profit Margin | -417.26% | -307.51% | -253.15% | 1.67% |
| Earnings Per Share | $-0.22 | $-0.18 | $-0.24 | $0.02 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$21.03M | -$22.54M | -$19.6M | $7.7M |
| Effective Tax Rate | 7.03% | 8.85% | 1.58% | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.